US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Respiratory/Pulmonary Market Research Reports & Industry Analysis

RSS Feeds

Respiratory/Pulmonary Industry Research & Market Reports

1    3    5  6  7  8  9  10  
USD 9,850
USD 4,350
Cold and Flu Drugs Markets in China
6/1/2014 | published by: Asia Market Information & Development Company
... continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term ...  |  read more...
USD 4,000
Respiratory Drugs Markets in China
6/1/2014 | published by: Asia Market Information & Development Company
... new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and ...  |  read more...
USD 4,000
USD 4,350
Global Spirometer Industry - 2014 Market Research Report
7/28/2014 | published by: 9Dimen Research
... region including North American, Europe and Asia etc, and the main country including United States, Germany, Japan and China etc. The report firstly introduced Spirometer basic information including Spirometer definition classification application and industry chain ...  |  read more...
USD 2,850
Emphysema - Pipeline Review, H1 2014
6/15/2014 | published by: Global Markets Direct
... Emphysema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Respiratory Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Ventilator Associated Pneumonia (VAP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Physician Views: What does the future hold for new EGFR targeting NSCLC therapies?
6/19/2014 | published by: FirstWord
... 12 to 18 months. Both products are initially being developed for patients who have seen their disease progress after treatment with currently available targeted therapies, by selection of those EGFR-positive patients with the T790m mutation ...  |  read more...
USD 645
OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update
7/7/2014 | published by: GlobalData
... and leads to life-threatening lung infections; and obstructs pancreatic enzyme secretions that are essential for the body to break down and absorb nutrients. CF patients have a limited number of available treatment options and significant ...  |  read more...
USD 7,995
Small-Cell Lung Cancer - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Small-Cell Lung Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Chronic Thromboembolic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014
8/30/2014 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Thromboembolic Pulmonary Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
USD 2,500
Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014
8/30/2014 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Neonatal Respiratory Distress Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
USD 2,500
Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014
8/30/2014 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Respiratory Distress Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
USD 2,500
USD 8,300
Respiratory Depression - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
... therapeutic development for Respiratory Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014
8/30/2014 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Adult Respiratory Distress Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
USD 2,500
Respiratory Partnering Terms and Agreements
8/1/2014 | published by: Current Partnering
... report provides a detailed understanding and analysis of how and why companies enter respiratory partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right ...  |  read more...
USD 1,995
Pulmonary Hypertension - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic development for Pulmonary Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Physician Views: How do pulmonologists value medical affairs teams – what could they be doing better?
7/9/2014 | published by: FirstWord
... efficient workings of healthcare systems. Not only do medical affairs personnel sit at an interface between the R&D and commercial spheres, but represent the voice of the company in communication with a growing range of ...  |  read more...
USD 645
Chronic Bronchitis - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic development for Chronic Bronchitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Respiratory Syncytial Virus (RSV) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Cough Drugs Markets in China
6/1/2014 | published by: Asia Market Information & Development Company
... new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and ...  |  read more...
USD 4,000
Lung Cancer Treatment Drugs Markets in China
6/1/2014 | published by: Asia Market Information & Development Company
... continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term ...  |  read more...
USD 4,000
1    3    5  6  7  8  9  10